"This price hike affects vital medications for conditions like asthma, tuberculosis, bipolar disorder, and glaucoma, which are essential for millions of citizens," Tagore said. Many patients and their ...
Amla, also referred to as Indian gooseberry, has a long history of use in Ayurvedic medicine. It is prized ... improve your hair and skin health, our list of the best Amla supplements has got ...
If you prefer VALORANT’s potent, one-tap-headshot rifle, the Vandal features some of the prettiest skins you can get. From lively animations to no-nonsense prints, Riot Games offers diverse ...
H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $135.00. Andrew Fein’s rating is based on the strong ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Two generic drugmakers, Apotex and Heritage Pharmaceuticals, have agreed to pay a combined $49 million to settle allegations they fixed prices on numerous medicines, the first such agreements ...
Dabur is a leading Indian multinational brand that manufactures Ayurvedic medicine ... Apis Himalaya Honey - Click here for Amazon deal Apis Himalaya Honey is another honey on the list sourced ...
"It is a matter of regret that the people of today are mostly dependent on allopathy rather than ayurveda. One should eat healthy, nutritious food and not depend on English medicine, making food ...
The Company emerged as a frontline manufacturer of speciality patent ayurvedic medicines - tussnil liposem and mathrukalpam. The company came out with a public issue in Feb.'95 to part-finance its ...
SCOM stock prices began rising at the beginning of October ... representing 100% of the company’s shareholding. Below is a list of the biggest Safaricom shareholders and the number of ordinary shares ...
Guggenheim analyst Michael Schmidt raised the firm’s price target on Revolution Medicines (RVMD) to $82 from $72 and keeps a Buy rating on the shares after the company presented initial Phase 1 ...